Yaroslav Shparyk

Researcher Next ID · RN-013692

Researcher · Medicine

, Ukraine

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Renal cell carcinoma treatment

HER2/EGFR in Cancer Research

Advanced Breast Cancer Therapies

Cancer Treatment and Pharmacology

Biosimilars and Bioanalytical Methods

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
The Lancet · 2016 · 10.1016/s0140-6736(16)32389-3
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
Journal of Clinical Oncology · 2015 · 10.1200/jco.2015.62.6598
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)71159-3
Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer
Journal of Clinical Oncology · 2006 · 10.1200/jco.2006.06.5821

No projects listed.